Cells that die during inflammation send wound-healing messages 

A study by the team of Prof. Kodi Ravichandran (VIB-UGent Center for Inflammation Research) and colleagues found that pyroptosis, a form of programmed cell death traditionally thought to be purely inflammatory, also plays a crucial role in promoting healing and tissue repair. This research, published in Nature, opens new avenues for understanding how our bodies respond to injury and could lead to innovative treatments for wounds and inflammatory diseases. 

Dying cells 

About a billion cells die in our bodies every day. Most of these cells are killed by a process called apoptosis, which is a form of cellular maintenance that keeps us healthy. ​ However, under the influence of pathogens or inflammatory triggers, cells can die in a process called pyroptosis. As the name suggests (pyro means fire), pyroptosis causes significant inflammation, which helps the body clear infections, but also causes severe tissue damage. ​ 

“Cell death by pyroptosis has so far only been regarded as inflammatory and damaging in nature, but our work suggests that, besides tissue-damaging factors, pyroptosis also releases beneficial molecules that encourage wound healing, which could lead to new treatments for dealing with chronic wounds or inflammation,” says Prof. Kodi Ravichandran (VIB-UGent), one of the lead authors of this study. ​ 

Inflammation and healing 

Whenever we face an injury or infection, our body responds by mounting an immune response, which results in inflammation clearing the infection. However, when the inflammation is not resolved in a timely or controlled manner, there can be excessive tissue damage. Cells undergoing pyroptosis contribute to this inflammation by releasing inflammatory molecules. ​ 

However, new research by the team of Prof. Kodi Ravichandran and colleagues finds that these pyroptotic cells also release molecules that can encourage wound healing. ​ 

“To our surprise, using cell culture and mouse model systems, the molecules secreted by pyroptotic cells are unique. ​ These molecules induce significant gene expression changes in nearby healthy immune cells (macrophages) that promote healing and tissue repair. So, pyroptosis presses both the accelerator and the brake; on the one hand inflammatory cytokines released from pyroptotic cells cause inflammation, while metabolites and oxylipins in the secretome help the tissue to heal itself” says Dr. Parul Mehrotra, a senior and first author on the study (VIB-UGent, now at Indian Institute of Technology, Delhi). 
Dr. Parul Mehrotra, Dr. Sophia Maschalidi, and Prof. Kodi Ravichandran.

Closing wounds 

One of the key wound-healing molecules that the researchers identified is prostaglandin E2, known for its role in pain and tissue regeneration. ​ 

Dr. Sophia Maschalidi (VIB-UGent), co-first author of this work, says: “Our experiments revealed that the secreted molecules from dying cells, known as the pyroptotic secretome, can significantly boost the body's ability to repair damaged tissues even when inflammatory molecules are present.” 

This study suggests that current strategies to develop treatments by blocking pyroptosis may need to be reconsidered. While this can prevent damage, it might also inhibit the release of essential molecules that aid in tissue repair. Instead, the newly identified small molecules and lipids from the pyroptotic secretome could be harnessed to develop new therapies, offering new hope for patients suffering from chronic wounds or inflammatory diseases. 


Funding 

This research was supported by the FWO, the Special Research Fund UGent, ERC, BJC Investigator Funds, LEO Foundation EMEA Award, Priority 2030 Federal Academic Leadership Program of the Russian Federation, EMBO, Boehringer Ingelheim, and the Lawrence C. Pakula, MD IBD Innovation Fund. 

Publication 

Oxylipins and metabolites from pyroptotic cells act as promoters of tissue repair. Mehrotra, Maschalidi, et al. Nature, 2024. DOI: 10.1038/s41586-024-07585-9 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

Share

Latest stories

Website preview
Molecular keyhole sheds light on pain and epilepsy
Leuven, 21 April 2026 – Researchers at VIB, VUB, and KU Leuven have identified a tiny binding site, a molecular ’keyhole’, in the TRPM3 ion channel, a crucial sensor in pain signaling. TRPM3 is also linked to rare neurodevelopmental disorders and epilepsy. In a recent study published in Nature Communications, the researchers found that even the slightest change in this keyhole can radically switch the channel’s behavior, explaining how certain mutations can flip the effects of drugs.
press.vib.be
Website preview
Designing better membrane proteins by embracing imperfection
Brussels, 14 April 2026 — Scientists at the VIB–VUB Center for Structural Biology have uncovered a counterintuitive principle that could reshape how membrane proteins are designed from scratch: sometimes, making a protein less stable helps it fold correctly. In a study published in Proceedings of the National Academy of Sciences (PNAS), researchers demonstrate that introducing carefully placed ‘imperfections’, a strategy known as negative design, enables synthetic membrane proteins to fold and assemble efficiently in artificial membranes.
press.vib.be
Website preview
Could the future of brewing be found in a remote Scandinavian farmhouse?
A large-scale genetic study of traditional farmhouse breweries in Scandinavia and the Baltic region has uncovered a remarkable reservoir of beer yeast diversity that may resemble the rich microbial landscape of Europe’s pre-industrial breweries. The study, led by Prof. Kevin Verstrepen (VIB and KU Leuven) and published in Current Biology, suggest that this living archive of yeasts could inspire a new generation of brewing innovation.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be